Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt University
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease (GVHD) by determining the qualitative and quantitative changes in T regulatory cells throughout the transplant process. Their understanding of this can lead to new treatment strategies and improved clinical therapeutic implications.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions
You may not be if
Patients \< 18 or \> 70 years old undergoing either autologous transplant or allogeneic transplant
Clareo Health | Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
